Mary Kay Inc., a global advocate for furthering young women’s education and encouraging youth to follow their STEM dreams, ...

Regeneron Pharmaceuticals (NASDAQ:REGN) operates within the biotechnology sector and is listed on Biggest Companies on Nasdaq ...

It's only a matter of time before cybercriminals begin to use artificial intelligence-enabled tools, open-source software and ...

U.S. equities fell at midday ahead of the release of the minutes of the latest Fed meeting and Nvidia's earnings news.

Dallas--(ANTARA/Business Wire)--Mary Kay Inc., a global advocate for furthering young women’s education and encouraging youth to follow their STEM dreams, returned for a second year as a Special ...

Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in ...

In light of the significant drop in Regeneron’s stock price, a natural question emerges: is REGN now a viable buying ...

Regeneron’s stock is having its worst day in 14 years after the failure of late-stage trial of its COPD treatment, after ...

Kymera's KT-621 achieved rapid, deep STAT6 degradation and showed a strong safety profile in Phase 1, with the next trials ...

Shares in both companies were lower after one study met the primary goal and a second missed its main target in their drug ...

Federal jurors in Delaware found that Amgen violated antitrust laws by bundling its cholesterol treatment with substantial ...